Wenyang Liu

发表

Adjuvant treatment may benefit patients with high-risk upper rectal cancer: A nomogram and recursive partitioning analysis of 547 patients

Jianyang Wang, Shulian Wang, J. Jin, 2016, Oncotarget.

Postoperative Chemoradiotherapy With Capecitabine and Oxaliplatin vs Capecitabine for Stage II to III Rectal Cancer

Chen Hu, Shulian Wang, J. Jin, 2021, JAMA network open.

Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR)

Chen Hu, Shulian Wang, Hai-tao Zhou, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy and toxicity of capecitabine combined with intensity-modulated radiotherapy after D1/D2 lymph node dissection in patients with gastric cancer

Shulian Wang, Dong-Bing Zhao, J. Jin, 2021, World journal of gastrointestinal oncology.

Preoperative Concurrent Chemoradiotherapy Versus Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: Phase II Randomized Study

Shulian Wang, C. Guo, Dong-Bing Zhao, 2022, Frontiers in Oncology.

Therapeutics , Targets , and Chemical Biology DNA Methylation-Mediated Repression of miR-886-3 p Predicts Poor Outcome of Human Small Cell Lung Cancer

Jingde Zhu, Q. Zhan, Yongmei Song, 2013 .

Clinical outcomes and radiation pneumonitis after concurrent EGFR‐tyrosine kinase inhibitors and radiotherapy for unresectable stage III non‐small cell lung cancer

Jun Liang, Jianyang Wang, Jie Wang, 2021, Thoracic cancer.

Down-staging depth score to predict outcomes in locally advanced rectal cancer achieving ypI stage after neoadjuvant chemo-radiotherapy versus de novo stage pI cohort: A propensity score-matched analysis.

Shulian Wang, J. Jin, H. Fang, 2018, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

The impact of age on the survival outcomes and risk of radiation pneumonitis in patients with unresectable locally advanced non-small cell lung cancer receiving chemoradiotherapy

Xin Wang, Jun Liang, Jianyang Wang, 2020, Journal of thoracic disease.

Antiemetic prophylaxis for chemoradiotherapy-induced nausea and vomiting in locally advanced head and neck squamous cell carcinoma: a prospective phase II trial

Yehui Zhang, J. Yi, Jingbo Wang, 2022, Strahlentherapie und Onkologie.

Antiemetic Prophylaxis for Chemoradiotherapy-Induced Nausea and Vomiting (C-RINV) in Locally Advanced Head and Heck Squamous Cell Carcinoma (LA-HNSCC): A Prospective Phase Ⅱ Trial

Yehui Zhang, J. Yi, Jingbo Wang, 2021 .

Survival benefit of surgery in patients with clinical T4 esophageal cancer who achieved complete or partial response after neoadjuvant chemoradiotherapy or radiotherapy

Jun Liang, Jianyang Wang, Zongmei Zhou, 2022, Therapeutic advances in medical oncology.

A Single Center Analysis of Thymic Neuroendocrine Tumors

Junling Li, Jianyang Wang, Zongmei Zhou, 2022, Cancers.

A Nomogram for Predicting Brain Metastasis in IIIA-N2 Non-Small Cell Lung Cancer After Complete Resection: A Competing Risk Analysis

Jun Liang, Jianyang Wang, Xu Yang, 2021, Frontiers in Oncology.

Comprehensive Pneumonitis Profile of Thoracic Radiotherapy Followed by Immune Checkpoint Inhibitor and Risk Factors for Radiation Recall Pneumonitis in Lung Cancer

X. Wang, Wei Tang, Weiting Jiang, 2022, Frontiers in Immunology.

A multicenter prospective phase III clinical randomized study of simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal cancer: 3JECROG P-02 study protocol

Jun Liang, Jianyang Wang, Zongmei Zhou, 2020, BMC cancer.

Comparison of setup errors of immobilization devices for thoracic radiotherapy.

Zongmei Zhou, Q. Feng, Xin Feng, 2022, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Downstaging depth score as a better surrogate endpoint than pCR, histological response and ypN0 for long-term outcomes in locally advanced gastric cancer patients after preoperative chemo-radiotherapy

Shulian Wang, Dong-Bing Zhao, J. Jin, 2020 .

Assessment and validation of the internal gross tumour volume of gastroesophageal junction cancer during simultaneous integrated boost radiotherapy

Shulian Wang, J. Jin, H. Fang, 2021, Radiation oncology.

Antiemetic prophylaxis for chemoradiotherapy-induced nausea and vomiting in locally advanced head and neck squamous cell carcinoma: a prospective phase II trial

Yehui Zhang, J. Yi, Jingbo Wang, 2022, Strahlentherapie und Onkologie.

A MicroRNA Signature Predicts Survival in Early Stage Small-Cell Lung Cancer Treated with Surgery and Adjuvant Chemotherapy

Jie He, Q. Zhan, Yongmei Song, 2014, PloS one.

A Validation Study on the Lung Immune Prognostic Index for Prognostic Value in Patients with Locally Advanced Non-Small Cell Lung Cancer.

Jun Liang, Jianyang Wang, Zongmei Zhou, 2021, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Response prediction and risk stratification of patients with rectal cancer after neoadjuvant therapy through an analysis of circulating tumour DNA

Y. Jiao, Shulian Wang, J. Jin, 2022, EBioMedicine.

S-1–Based Chemoradiotherapy Followed by Consolidation Chemotherapy With S-1 in Elderly Patients With Esophageal Squamous Cell Carcinoma: A Multicenter Phase II Trial

W. Wang, Jun Liang, Xinchen Sun, 2020, Frontiers in Oncology.

Local Therapy Combined With First-Line EGFR Tyrosine Kinase Inhibitor Achieves Favorable Survival in Patients With EGFR-Mutant Metastatic Non-Small Cell Lung Cancer

Jun Liang, Jianyang Wang, Zongmei Zhou, 2022, Clinical Medicine Insights. Oncology.

LncRNA and mRNA signatures associated with neoadjuvant chemoradiotherapy downstaging effects in rectal cancer

Zhihua Liu, A. Luo, Shulian Wang, 2018, Journal of cellular biochemistry.

DNA methylation-mediated repression of miR-886-3p predicts poor outcome of human small cell lung cancer.

Jingde Zhu, Kelong Ma, Yinghua He, 2013, Cancer research.

Applying post-neoadjuvant pathologic stage as prognostic tool in esophageal squamous cell carcinoma

Q. Xue, Jun Liang, Y. Mao, 2022, Frontiers in Oncology.

Case report: Radiotherapy plus pneumococcal conjugate vaccine stimulates abscopal immune response in a patient with ALK+ NSCLC

Zhuo Li, Yong Huang, Wenyang Liu, 2022, Frontiers in Immunology.

MiR-92b targets p57kip2 to modulate the resistance of hepatocellular carcinoma (HCC) to ionizing radiation (IR) -based radiotherapy.

Ning Li, Jianyang Wang, J. Cai, 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

The safety of an MRI simulation-guided boost after short-course preoperative radiotherapy for unresectable rectal cancer (SUNRISE): interim analysis of a randomized phase II trial

Shulian Wang, Hai-tao Zhou, J. Jin, 2022, Radiation Oncology.

Development and validation of a prediction model using molecular marker for long‐term survival in unresectable stage III non‐small cell lung cancer treated with chemoradiotherapy

Jun Liang, Jianyang Wang, Zongmei Zhou, 2021, Thoracic cancer.

Possible contribution of IMRT in postoperative radiochemotherapy for rectal cancer: analysis on 1798 patients by prediction model

V. Valentini, G. Chiloiro, N. Dinapoli, 2016, Oncotarget.

Metastasis risk stratification and response prediction through dynamic viable circulating tumor cell counts for rectal cancer in a neoadjuvant setting

Shulian Wang, Kai Zhang, Yuan Tang, 2023, Cancer medicine.

Induction Immune Checkpoint Inhibitors and Chemotherapy before Definitive Chemoradiation Therapy for Patients with Bulky Unresectable Stage III Non-small-cell Lung Cancer.

Q. Xue, Jianyang Wang, Zhijie Wang, 2023, International journal of radiation oncology, biology, physics.

Effectiveness of S-1–Based Chemoradiotherapy in Patients 70 Years and Older With Esophageal Squamous Cell Carcinoma

Xinchen Sun, Jianyang Wang, Zongmei Zhou, 2023, JAMA network open.

Postoperative radiotherapy for pathological stage IIIA‐N2 non‐small cell lung cancer with positive surgical margins

Jun Liang, Jianyang Wang, Xu Yang, 2020, Thoracic cancer.

Safety and efficacy of preoperative chemoradiotherapy in fit older patients with intermediate or locally advanced rectal cancer evaluated by comprehensive geriatric assessment: A planned interim analysis of a multicenter, phase II trial.

Xi-shan Wang, Shulian Wang, Zhixiang Zhou, 2020, Journal of geriatric oncology.

Tomotherapy as an adjuvant treatment for gastroesophageal junction and stomach cancer may reduce bowel and bone marrow toxicity compared to intensity-modulated radiotherapy and volumetric-modulated arc therapy

Zhihui Hu, J. Jin, H. Fang, 2017, Oncotarget.

Preoperative versus postoperative chemo-radiotherapy for locally advanced gastric cancer: a multicenter propensity score-matched analysis

L. Yang, Shulian Wang, J. Jin, 2022, BMC Cancer.

Down-staging depth score could be a survival predictor for locally advanced gastric cancer patients after preoperative chemoradiotherapy

Shulian Wang, J. Jin, H. Fang, 2021, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

Preoperative Versus Postoperative Chemo-Radiotherapy For Locally Advanced Gastric Cancer: A Propensity Score-Matched Analysis

Shulian Wang, J. Jin, H. Fang, 2021 .

A prospective phase I study of hypo-fractionated neoadjuvant radiotherapy for locally advanced gastric cancer

Shulian Wang, J. Jin, H. Fang, 2018, BMC cancer.

Gefitinib for asymptomatic brain metastasis from advanced non‐small cell lung cancer: Report of a favourable outcome

P. Liu, Yan Wang, Z. Hui, 2016, Thoracic cancer.

Nomogram for predicting the overall survival of patients after D2/R0 resection and chemoradiotherapy for stage III gastric cancer or gastroesophageal junction cancer

J. Jin, W. Kang, Yuan Tang, 2023, Radiation Medicine and Protection.

Chemoradiotherapy is an alternative choice for patients with primary mediastinal seminoma

Jianyang Wang, Zongmei Zhou, Shulian Wang, 2021, Radiation oncology.

A prospective phase I study of hypo-fractionated neoadjuvant radiotherapy for locally advanced gastric cancer

Shulian Wang, J. Jin, H. Fang, 2018, BMC Cancer.

Efficacy and safety of definitive chemoradiotherapy with or without induction immune checkpoint inhibitors in patients with stage III non-small cell lung cancer

Q. Xue, Jianyang Wang, Zongmei Zhou, 2023, Frontiers in immunology.

Induction PD-1 inhibitor toripalimab plus chemotherapy followed by concurrent chemoradiotherapy and consolidation toripalimab for bulky locally advanced non-small-cell lung cancer: protocol for a randomized phase II trial (InTRist study)

Jianyang Wang, Zongmei Zhou, Q. Feng, 2024, Frontiers in Immunology.

Hippocampal avoidance whole-brain radiotherapy with simultaneous integrated boost in lung cancer brain metastases and utility of the Hopkins verbal learning test for testing cognitive impairment in Chinese patients: a prospective phase II study

Zongmei Zhou, Q. Feng, Y. Zhai, 2024, BMC Cancer.

Conversion chemoradiotherapy combined with nab-paclitaxel plus cisplatin in patients with locally advanced borderline-resectable or unresectable esophageal squamous cell carcinoma: a phase i/ii prospective cohort study.

Zongmei Zhou, Q. Feng, Tao Zhang, 2024, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].